<?xml version="1.0" encoding="UTF-8"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-10-18T23:53:50Z</responseDate><request verb="GetRecord" identifier="oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10370" metadataPrefix="oai_dc">https://ebyu-rdlopen.rawdatalibrary.net/oai/request</request><GetRecord><record><header><identifier>oai:ebyu-rdlopen.rawdatalibrary.net:ebyu/10370</identifier><datestamp>2026-10-18T20:25:35Z</datestamp><setSpec>openaire</setSpec><setSpec>driver</setSpec><setSpec>com_ebyu_10000</setSpec><setSpec>col_ebyu_10001</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:title>Solution-phase multifunctional modulation of cholinesterases and carbonic anhydrases by thiourea–pyrimidine benzenesulfonamides: Kinetics and explicit-solvent molecular dynamics</dc:title><dc:creator>Tok, Fatih</dc:creator><dc:creator>Dumani, Alessia</dc:creator><dc:creator>Güney, Sultan</dc:creator><dc:creator>Abas, Burçin İrem</dc:creator><dc:creator>Kozan, Bensu</dc:creator><dc:creator>Türkeş, Cüneyt</dc:creator><dc:creator>Duran, Hatice Esra</dc:creator><dc:creator>Başoğlu, Faika</dc:creator><dc:creator>Çevik, Özge</dc:creator><dc:creator>Ece, Abdulilah</dc:creator><dc:subject>Aqueous solution</dc:subject><dc:subject>Carbonic anhydrases</dc:subject><dc:subject>Cholinesterases</dc:subject><dc:subject>Enzyme kinetics</dc:subject><dc:subject>Explicit-solvent molecular dynamics</dc:subject><dc:subject>Nonlinear global fitting</dc:subject><dc:subject>Solvent-mediated recognition</dc:subject><dc:subject>Thiourea–pyrimidine benzenesulfonamides</dc:subject><dc:subject>Binding energy</dc:subject><dc:subject>Cell culture</dc:subject><dc:subject>Cytotoxicity</dc:subject><dc:subject>Enzyme inhibition</dc:subject><dc:subject>Global optimization</dc:subject><dc:subject>Kinetics</dc:subject><dc:subject>Lead compounds</dc:subject><dc:subject>Ligands</dc:subject><dc:subject>Rate constants</dc:subject><dc:subject>Solvents</dc:subject><dc:subject>Anhydrase</dc:subject><dc:subject>Benzenesulfonamide</dc:subject><dc:subject>Cholinesterase</dc:subject><dc:subject>Enzymes kinetics</dc:subject><dc:subject>Explicit solvent molecular dynamics</dc:subject><dc:subject>Global fitting</dc:subject><dc:subject>Solution phase</dc:subject><dc:subject>Thiourea–pyrimidine benzenesulphonamide</dc:subject><dc:subject>Carbonic anhydrase</dc:subject><dc:subject>Molecular dynamics</dc:subject><dc:subject>Thioureas</dc:subject><dc:description>In aqueous media, enzyme–ligand recognition is shaped not only by direct contacts but also by solvent-mediated interaction networks that persist across time scales. Here, cholinesterases (AChE and BChE) and cytosolic human carbonic anhydrases ( h CA I and h CA II) were investigated as two disease-relevant enzyme systems in solution, and twelve thiourea–pyrimidine benzenesulfonamide derivatives were synthesized and structurally characterized. Enzyme inhibition was quantified by steady-state kinetics; inhibition constants ( K I) were obtained by nonlinear global fitting of untransformed rate data, with Lineweaver–Burk plots used only for visualization. To connect solution-phase inhibition with molecular recognition, docking was validated by redocking (heavy-atom RMSD &lt;2.0 Å across targets), and representative complexes were examined by 500 ns explicit-solvent MD simulations (TIP3P, 0.15 M NaCl, NPT), revealing stable binding modes and persistent, frequently water-mediated interaction patterns consistent with experimental trends. Cellular relevance was assessed in MKN-28 gastric cancer cells with L929 fibroblasts as a non-malignant control. Compounds with improved cytotoxic selectivity toward MKN-28 were identified, and the lead compound ( 11 ) was further evaluated by Annexin V/PI flow cytometry, showing a shift from viable cells toward apoptotic populations under the tested conditions. In silico ADMET profiling suggested moderate lipophilicity across the series, while highlighting elevated polar surface area and compound-dependent toxicity flags as parameters to monitor during optimization. Overall, thiourea–pyrimidine benzenesulfonamides emerge as multifunctional modulators of ChEs and cytosolic h CAs within the applied biochemical and cellular assays. © 2026 Elsevier B.V.</dc:description><dc:publisher>Elsevier B.V.</dc:publisher><dc:date>2026</dc:date><dc:type>Article</dc:type><dc:identifier>https://rdlopen.rawdatalibrary.net/r/ebyu/10370</dc:identifier><dc:identifier>https://doi.org/10.1016/j.molliq.2026.129456</dc:identifier><dc:identifier>0167-7322</dc:identifier><dc:language>en</dc:language><dc:relation>Journal of Molecular Liquids</dc:relation><dc:rights>info:eu-repo/semantics/openAccess</dc:rights><dc:type>info:eu-repo/semantics/article</dc:type><dc:identifier>https://ebyu-rdlopen.rawdatalibrary.net/tr/items/ebyu/10370</dc:identifier></oai_dc:dc></metadata></record></GetRecord></OAI-PMH>